跳至主要内容
临床试验/CTRI/2021/10/037630
CTRI/2021/10/037630尚未招募2 期

Clinical Trial to Evaluate the Safety and Efficacy of Siddha Medicine Nandhi Mezhugu in Stage 1 and 2 Breast Cancer Patients

Central Council for Research in Siddha Arumbakkam Chennai0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Female patients in the age group of 18- 60 years
  • 2.Patients with histologically/cytologically confirmed carcinoma of the breast of stages I & II.
  • 3.Patient willing to take siddha medicine
  • 4.Patients ready to consent and to abide to trial related procedures

排除标准

  • 1.Patient willing to take chemotherapy/radiotherapy/ undergo surgery/ any other alternative medicines
  • 2.Patients who have received prior chemotherapy/ hormonal therapy/ investigational drugs/ alternative therapies for the treatment of breast cancer within last 1 month
  • 3.Patients who have under gone surgery for stage I & II breast cancer
  • 4.Patients with stage III and IV (who are with distant metastasis at diagnosis)
  • 5.Patients with severe illness
  • 6.Patients with significant existing breast trauma
  • 7.Patients with abnormal renal & liver functions
  • 8.Confirmed diagnosis of HIV or Hepatitis B/C
  • 9.Inability to comply with the study protocol
  • 10.Pre-menopausal female patients who are pregnant, lactating or of reproductive potential and not employing effective birth control measures

研究者

发起方
Central Council for Research in Siddha Arumbakkam Chennai

相似试验